How does Venclexta work?
Medically reviewed by Drugs.com Last updated on May 20, 2019.
Official Answerby Drugs.com
Venclexta (venetoclax) is an oral B-cell lymphoma-2 (BCL-2) inhibitor for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL), and acute myeloid leukemia (AML).
The BCL-2 protein prevents apoptosis (programmed cell death) of some cells, including lymphocytes, and it can be highly expressed in CLL and AML. Venetoclax is designed to selectively inhibit the function of the BCL-2 protein, leading to the restoration of the signaling system that tells the cancer cells to self-destruct.
Related Medical Questions
- What is the difference between Rituxan and Rituxan Hycela?
- What are the names of the BTK inhibitors?
- What type of drug is Copiktra?
- What is the difference between Truxima and Rituxan?
- How do you prepare for a Rituxan infusion?
- How does the drug Rituxan work?
- How long does it take for Rituxan to work?